Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1972 1
1982 2
1984 1
1985 1
1986 2
1987 2
1989 1
1990 3
1991 1
1992 2
1993 5
1994 3
1995 1
1996 2
1997 6
1998 7
1999 1
2000 2
2002 3
2003 2
2004 11
2005 13
2006 7
2007 4
2008 6
2009 6
2010 5
2011 6
2012 3
2013 5
2014 8
2015 11
2016 10
2017 13
2018 11
2019 19
2020 19
2021 13
2022 16
2023 12
2024 12
2025 16
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

261 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean makiguchi n[au] (9 results)?
Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study.
Kuruvilla J, Ramchandren R, Santoro A, Paszkiewicz-Kozik E, Gasiorowski R, Johnson NA, Fogliatto LM, Goncalves I, de Oliveira JSR, Buccheri V, Perini GF, Goldschmidt N, Kriachok I, Dickinson M, Komarnicki M, McDonald A, Ozcan M, Sekiguchi N, Zhu Y, Nahar A, Marinello P, Zinzani PL; KEYNOTE-204 investigators. Kuruvilla J, et al. Among authors: sekiguchi n. Lancet Oncol. 2021 Apr;22(4):512-524. doi: 10.1016/S1470-2045(21)00005-X. Epub 2021 Mar 12. Lancet Oncol. 2021. PMID: 33721562 Clinical Trial.
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: a post hoc analysis of KEYNOTE-204 by prior lines of therapy.
Kuruvilla J, Modi D, Santoro A, Paszkiewicz-Kozik E, Gasiorowski R, Johnson NA, Fogliatto LM, Gonçalves I, de Oliveira J, Buccheri V, Perini GF, Goldschmidt N, Kriachok I, Sekiguchi N, Lin J, Yusuf R, Marinello P, Zinzani PL. Kuruvilla J, et al. Among authors: sekiguchi n. Leuk Lymphoma. 2025 Sep;66(9):1710-1719. doi: 10.1080/10428194.2025.2502805. Epub 2025 Jun 23. Leuk Lymphoma. 2025. PMID: 40548833 Free article. Clinical Trial.
The Impact of Tirabrutinib Monotherapy for the Treatment of Bing-Neel Syndrome: A Multicenter Retrospective Study.
Saburi M, Masunari T, Fukuhara N, Inagaki Y, Shimura A, Imoto N, Hasegawa Y, Hagihara M, Kobayashi N, Kumekawa H, Nakazawa H, Miyazaki K, Kawakita T, Isshiki T, Katsube A, Fujisawa S, Horigome Y, Koba Y, Jinnouchi F, Sekiguchi N. Saburi M, et al. Among authors: sekiguchi n. Am J Hematol. 2025 Oct;100(10):1912-1915. doi: 10.1002/ajh.70029. Epub 2025 Aug 2. Am J Hematol. 2025. PMID: 40751704 Free PMC article. No abstract available.
Myxoid meningioma in a dog.
Sekiguchi N, Shiozawa N, Ishikawa C, Kitagawa M, Nakayama T, Ito D. Sekiguchi N, et al. J Small Anim Pract. 2023 Feb;64(2):118. doi: 10.1111/jsap.13576. Epub 2022 Nov 25. J Small Anim Pract. 2023. PMID: 36428278 No abstract available.
Report of Consensus Panel 2 from the 12th International Workshop on the management of Bing-Neel syndrome in patients with Waldenstrom's Macroglobulinemia.
Sarosiek S, Becking AL, Branagan A, Ferrero S, Khwaja J, Kimby E, Roos-Weil D, Sekiguchi N, Trneny M, Yi S, Patterson CJ, Buske C, Matous JV, Treon SP, Minnema MC. Sarosiek S, et al. Among authors: sekiguchi n. Semin Hematol. 2025 Apr;62(2):85-89. doi: 10.1053/j.seminhematol.2025.04.005. Epub 2025 Apr 16. Semin Hematol. 2025. PMID: 40414752
Association between gene mutations and outcomes in Japanese high-risk AML patients: a phase 1/2 study of NS-87/CPX-351.
Makishima H, Mikasa T, Isogaya K, Miyamoto T, Yamauchi T, Yokota A, Onozawa M, Ando K, Ogawa Y, Usuki K, Yamauchi T, Ota S, Takada S, Morita Y, Ishikawa T, Takenaka K, Kuroda J, Sekiguchi N, Kawakita T, Miyazaki Y. Makishima H, et al. Among authors: sekiguchi n. Int J Hematol. 2025 Jul;122(1):57-65. doi: 10.1007/s12185-025-03956-8. Epub 2025 Feb 27. Int J Hematol. 2025. PMID: 40016445 Free PMC article. Clinical Trial.
Report of Consensus Panel 4 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with non-IgM lymphoplasmacytic lymphoma.
Tedeschi A, Auer R, Autore F, Castillo JJ, Gatt ME, Kimby E, Moreno DF, Owen RG, Qiu L, Roccaro AM, Sarosiek S, Sekiguchi N, Seymour JF, Varettoni M, Patterson CJ, Matous JV, Buske C, Treon SP, Sanz RG. Tedeschi A, et al. Among authors: sekiguchi n. Semin Hematol. 2025 Apr;62(2):106-112. doi: 10.1053/j.seminhematol.2025.04.002. Epub 2025 Apr 8. Semin Hematol. 2025. PMID: 40382197
261 results